Showing results (1-10 of 575) with videos related to
Sort By:
Pageof 58
Antioxidants (Basel, Switzerland)|June 24, 2022
Resveratrol in Treating Diabetes and Its Cardiovascular Complications: A Review of Its Mechanisms of ActionMeiming Su, Wenqi Zhao, Suowen Xu, et al.Nutrients|November 11, 2022
Genome-Wide Transcriptional Profiling Reveals PHACTR1 as a Novel Molecular Target of Resveratrol in Endothelial HomeostasisMeiming Su, Wenqi Zhao, Yujie Li, et al.Trends in Endocrinology and Metabolism: TEM|April 20, 2020
Familial Hypercholesterolemia and Atherosclerosis: Animal Models and Therapeutic AdvancesSuowen Xu, Jianping WengJournal of Diabetes Investigation|July 15, 2022
Hyperglycemia-mediated oocyte TET3 insufficiency predisposes offspring to glucose intoleranceXiumei Wu, Suowen Xu, Jianping WengFrontiers in Immunology|July 22, 2022
Endothelial Cells as a Key Cell Type for Innate Immunity: A Focused Review on RIG-I Signaling PathwaySuowen Xu, Tengchuan Jin, Jianping WengTrends in Molecular Medicine|June 14, 2022
Marijuana and endothelial dysfunction: new mechanism and therapyXiaojun Feng, Suowen Xu, Jianping WengResearch (Washington, D.C.)|February 20, 2025
Prioritization of Lipid Metabolism Targets for the Diagnosis and Treatment of Cardiovascular DiseasesZhihua Wang, Shuo Chen, Fanshun Zhang, et al.International Journal of Biological Sciences|January 3, 2023
Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicineHuiling Tan, Tong Yue, Zhengfang Chen, et al.Frontiers in Immunology|September 29, 2022
Vascular homeostasis in atherosclerosis: A holistic overviewSuowen Xu, Qing Rex Lyu, Iqra Ilyas, et al.Diabetes, Obesity & Metabolism|May 28, 2021
Targeting angiopoietin-like 3 in atherosclerosis: From bench to bedsidePing Ling, Xueying Zheng, Sihui Luo, et al.Pageof 58